PDT Partners’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
120,327
+31,750
| +36% | +$350K | 0.08% | 370 |
|
|
2025
Q1 | $791K | Buy |
88,577
+50,901
| +135% | +$455K | 0.06% | 435 |
|
|
2024
Q4 | $355K | Sell |
37,676
-49,501
| -57% | -$466K | 0.03% | 540 |
|
|
2024
Q3 | $703K | Buy |
87,177
+20,738
| +31% | +$167K | 0.06% | 442 |
|
|
2024
Q2 | $563K | Hold |
66,439
| – | – | 0.05% | 441 |
|
|
2024
Q1 | $596K | Buy |
66,439
+34,016
| +105% | +$305K | 0.06% | 421 |
|
|
2023
Q4 | $364K | Sell |
32,423
-49,035
| -60% | -$551K | 0.04% | 444 |
|
|
2023
Q3 | $703K | Sell |
81,458
-700
| -0.9% | -$6.04K | 0.09% | 360 |
|
|
2023
Q2 | $850K | Sell |
82,158
-203
| -0.2% | -$2.1K | 0.12% | 284 |
|
|
2023
Q1 | $894K | Buy |
82,361
+39
| +0% | +$423 | 0.12% | 290 |
|
|
2022
Q4 | $924K | Buy |
82,322
+664
| +0.8% | +$7.45K | 0.15% | 246 |
|
|
2022
Q3 | $828K | Sell |
81,658
-74,473
| -48% | -$755K | 0.13% | 276 |
|
|
2022
Q2 | $1.42M | Sell |
156,131
-36,570
| -19% | -$331K | 0.12% | 264 |
|
|
2022
Q1 | $1.84M | Buy |
192,701
+81,322
| +73% | +$777K | 0.16% | 195 |
|
|
2021
Q4 | $1.23M | Buy |
+111,379
| New | +$1.23M | 0.09% | 318 |
|
|
2021
Q1 | – | Sell |
-54,522
| Closed | -$969K | – | 881 |
|
|
2020
Q4 | $969K | Sell |
54,522
-11,539
| -17% | -$205K | 0.07% | 328 |
|
|
2020
Q3 | $977K | Buy |
66,061
+41,447
| +168% | +$613K | 0.06% | 308 |
|
|
2020
Q2 | $517K | Buy |
+24,614
| New | +$517K | 0.04% | 402 |
|
|
2015
Q4 | – | Sell |
-17,683
| Closed | -$194K | – | 904 |
|
|
2015
Q3 | $194K | Sell |
17,683
-25,244
| -59% | -$277K | ﹤0.01% | 1165 |
|
|
2015
Q2 | $559K | Buy |
42,927
+26,534
| +162% | +$346K | 0.01% | 939 |
|
|
2015
Q1 | $284K | Buy |
+16,393
| New | +$284K | 0.01% | 1174 |
|